HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased Adipose Tissue Fibrogenesis, Not Impaired Expandability, Is Associated With Nonalcoholic Fatty Liver Disease.

AbstractBACKGROUND AND AIMS:
It is proposed that impaired expansion of subcutaneous adipose tissue (SAT) and an increase in adipose tissue (AT) fibrosis causes ectopic lipid accumulation, insulin resistance (IR), and metabolically unhealthy obesity. We therefore evaluated whether a decrease in SAT expandability, assessed by measuring SAT lipogenesis (triglyceride [TG] production), and an increase in SAT fibrogenesis (collagen production) are associated with NAFLD and IR in persons with obesity.
APPROACH AND RESULTS:
In vivo abdominal SAT lipogenesis and fibrogenesis, expression of SAT genes involved in extracellular matrix (ECM) formation, and insulin sensitivity were assessed in three groups of participants stratified by adiposity and intrahepatic TG (IHTG) content: (1) healthy lean with normal IHTG content (Lean-NL; n = 12); (2) obese with normal IHTG content and normal glucose tolerance (Ob-NL; n = 25); and (3) obese with NAFLD and abnormal glucose metabolism (Ob-NAFLD; n = 25). Abdominal SAT TG synthesis rates were greater (P < 0.05) in both the Ob-NL (65.9 ± 4.6 g/wk) and Ob-NAFLD groups (71.1 ± 6.7 g/wk) than the Lean-NL group (16.2 ± 2.8 g/wk) without a difference between the Ob-NL and Ob-NAFLD groups. Abdominal SAT collagen synthesis rate and the composite expression of genes encoding collagens progressively increased from the Lean-NL to the Ob-NL to the Ob-NAFLD groups and were greater in the Ob-NAFLD than the Ob-NL group (P < 0.05). Composite expression of collagen genes was inversely correlated with both hepatic and whole-body insulin sensitivity (P < 0.001).
CONCLUSIONS:
AT expandability is not impaired in persons with obesity and NAFLD. However, SAT fibrogenesis is greater in persons with obesity and NAFLD than in those with obesity and normal IHTG content, and is inversely correlated with both hepatic and whole-body insulin sensitivity.
AuthorsJoseph W Beals, Gordon I Smith, Mahalakshmi Shankaran, Anja Fuchs, George G Schweitzer, Jun Yoshino, Tyler Field, Marcy Matthews, Edna Nyangau, Darya Morozov, Bettina Mittendorfer, Marc K Hellerstein, Samuel Klein
JournalHepatology (Baltimore, Md.) (Hepatology) Vol. 74 Issue 3 Pg. 1287-1299 (09 2021) ISSN: 1527-3350 [Electronic] United States
PMID33743554 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2021 by the American Association for the Study of Liver Diseases.
Chemical References
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Triglycerides
  • Collagen
Topics
  • Adipose Tissue (metabolism)
  • Adult
  • Collagen (metabolism)
  • Extracellular Matrix (metabolism)
  • Female
  • Fibrosis
  • Glucose Intolerance (complications, metabolism)
  • Humans
  • Insulin Resistance
  • Lipogenesis
  • Male
  • NLR Family, Pyrin Domain-Containing 3 Protein (metabolism)
  • Non-alcoholic Fatty Liver Disease (complications, metabolism)
  • Obesity (complications, metabolism)
  • Subcutaneous Fat (metabolism)
  • Subcutaneous Fat, Abdominal (metabolism)
  • Triglycerides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: